ITOS – ITeos Therapeutics Inc
ITOS
$7.41Name : iTeos Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $270,716,192.00
EPSttm : -3.14
iTeos Therapeutics, Inc.
$7.41
Float Short %
4.57
Margin Of Safety %
Put/Call OI Ratio
5.7
EPS Next Q Diff
0.05
EPS Last/This Y
EPS This/Next Y
-0.51
Price
7.41
Target Price
20.6
Analyst Recom
1
Performance Q
-5.96
Relative Volume
0.71
Beta
1.38
Ticker: ITOS
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-01-23 | ITOS | 7.67 | 3.29 | 1.00 | 11574 |
2025-01-24 | ITOS | 7.63 | 3.29 | 999.99 | 11574 |
2025-01-27 | ITOS | 7.53 | 3.29 | 0.10 | 11576 |
2025-01-28 | ITOS | 7.5 | 3.28 | 999.99 | 11586 |
2025-01-29 | ITOS | 7.49 | 3.28 | 0.00 | 11591 |
2025-01-30 | ITOS | 7.7 | 3.24 | 0.07 | 11625 |
2025-01-31 | ITOS | 7.54 | 3.23 | 0.08 | 11634 |
2025-02-03 | ITOS | 7.36 | 3.22 | 999.99 | 11644 |
2025-02-04 | ITOS | 7.48 | 3.22 | 2.00 | 11644 |
2025-02-05 | ITOS | 7.82 | 3.22 | 0.00 | 11646 |
2025-02-06 | ITOS | 7.77 | 3.21 | 0.04 | 11650 |
2025-02-07 | ITOS | 7.59 | 3.24 | 0.00 | 11625 |
2025-02-10 | ITOS | 7.19 | 2.91 | 0.08 | 11935 |
2025-02-11 | ITOS | 7.16 | 2.56 | 63.34 | 10930 |
2025-02-12 | ITOS | 7.29 | 4.18 | 0.00 | 15946 |
2025-02-13 | ITOS | 7.26 | 4.14 | 999.99 | 15981 |
2025-02-14 | ITOS | 7.39 | 4.13 | 999.99 | 15979 |
2025-02-18 | ITOS | 7.43 | 5.75 | 999.99 | 20999 |
2025-02-19 | ITOS | 7.49 | 5.75 | 0.00 | 21000 |
2025-02-20 | ITOS | 7.47 | 5.71 | 0.00 | 21023 |
2025-02-21 | ITOS | 7.41 | 5.70 | 91.00 | 21027 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-01-23 | ITOS | 7.67 | -20.2 | - | -3.15 |
2025-01-24 | ITOS | 7.64 | -20.2 | - | -3.15 |
2025-01-27 | ITOS | 7.54 | -20.2 | - | -3.15 |
2025-01-28 | ITOS | 7.51 | -20.2 | - | -3.15 |
2025-01-29 | ITOS | 7.48 | -20.2 | - | -3.15 |
2025-01-30 | ITOS | 7.68 | -20.2 | - | -3.15 |
2025-01-31 | ITOS | 7.54 | -20.2 | - | -3.15 |
2025-02-03 | ITOS | 7.37 | -20.2 | - | -3.15 |
2025-02-04 | ITOS | 7.48 | -20.2 | - | -3.15 |
2025-02-05 | ITOS | 7.81 | -20.2 | - | -3.15 |
2025-02-06 | ITOS | 7.77 | -20.2 | - | -3.15 |
2025-02-07 | ITOS | 7.60 | -20.2 | - | -3.15 |
2025-02-10 | ITOS | 7.18 | -20.2 | - | -3.15 |
2025-02-11 | ITOS | 7.16 | -20.2 | - | -3.15 |
2025-02-12 | ITOS | 7.29 | -20.2 | - | -3.15 |
2025-02-13 | ITOS | 7.27 | -20.2 | - | -3.15 |
2025-02-14 | ITOS | 7.40 | -20.2 | - | -3.15 |
2025-02-18 | ITOS | 7.43 | -20.2 | - | -3.15 |
2025-02-19 | ITOS | 7.50 | -20.2 | - | -3.15 |
2025-02-20 | ITOS | 7.48 | -20.2 | - | -3.15 |
2025-02-21 | ITOS | 7.41 | -20.2 | - | -3.15 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-01-23 | ITOS | 0.09 | 3.36 | 4.88 |
2025-01-24 | ITOS | 0.09 | 3.36 | 4.88 |
2025-01-27 | ITOS | 0.09 | 3.18 | 4.88 |
2025-01-28 | ITOS | 0.09 | 3.18 | 4.35 |
2025-01-29 | ITOS | 0.09 | 3.18 | 4.35 |
2025-01-30 | ITOS | 0.09 | 3.18 | 4.35 |
2025-01-31 | ITOS | 0.09 | 3.18 | 4.35 |
2025-02-03 | ITOS | 0.09 | 3.17 | 4.37 |
2025-02-04 | ITOS | 0.09 | 3.17 | 4.37 |
2025-02-05 | ITOS | 0.09 | 3.17 | 4.35 |
2025-02-06 | ITOS | 0.09 | 3.17 | 4.35 |
2025-02-07 | ITOS | 0.09 | 3.17 | 4.35 |
2025-02-10 | ITOS | 0.09 | 3.91 | 4.35 |
2025-02-11 | ITOS | 0.08 | 3.91 | 4.37 |
2025-02-12 | ITOS | 0.08 | 3.91 | 4.59 |
2025-02-13 | ITOS | 0.09 | 3.91 | 4.57 |
2025-02-14 | ITOS | 0.09 | 3.91 | 4.57 |
2025-02-18 | ITOS | 0.09 | -1.62 | 4.57 |
2025-02-19 | ITOS | 0.07 | -1.62 | 4.72 |
2025-02-20 | ITOS | 0.07 | -1.62 | 4.72 |
2025-02-21 | ITOS | 0.09 | -1.62 | 4.57 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-1.05
Avg. EPS Est. Current Quarter
-1.02
Avg. EPS Est. Next Quarter
-1
Insider Transactions
0.09
Institutional Transactions
-1.62
Beta
1.38
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
26
Growth Score
29
Sentiment Score
83
Actual DrawDown %
85.9
Max Drawdown 5-Year %
Target Price
20.6
P/E
Forward P/E
PEG
P/S
7.73
P/B
0.43
P/Free Cash Flow
EPS
-3.15
Average EPS Est. Cur. Y
-3.15
EPS Next Y. (Est.)
-3.66
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-346.44
Relative Volume
0.71
Return on Equity vs Sector %
-38.4
Return on Equity vs Industry %
-22.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.22
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 157
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonists that is in Phase 1/2a clinical trials to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment; and EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to inhibit the immunosuppressive activity of adenosine and restore immune cell proliferation is in Phase 1 clinical trials. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
stock quote shares ITOS – ITeos Therapeutics Inc Stock Price stock today
news today ITOS – ITeos Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ITOS – ITeos Therapeutics Inc yahoo finance google finance
stock history ITOS – ITeos Therapeutics Inc invest stock market
stock prices ITOS premarket after hours
ticker ITOS fair value insiders trading